Related Experiment Video
Updated: Dec 28, 2025
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Synthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma
Linsong Tang1, Ronggao Chen1, Xiao Xu1
1Department of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; NHFPC Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, 310003, China.
Abstract:
Hepatocellular carcinoma (HCC), the main cause of liver cancer-related death, is one of the main cancers in terms of incidence and mortality. However, HCC is difficult to target and develops strong drug resistance. Therefore, a new treatment strategy is urgently needed. The clinical application of the concept of synthetic lethality in recent years provides a new therapeutic direction for the accurate treatment of HCC. Here, we introduce the concept of synthetic lethality, the screening used to study synthetic lethality, and the identified and potential genetic interactions that induce synthetic lethality in HCC. In addition, we propose opportunities and challenges for translating synthetic lethal interactions to the clinical treatment of HCC.
Insights
Hepatocellular carcinoma (HCC) is a deadly liver cancer with poor treatment options. Synthetic lethality offers a promising new strategy for targeted HCC therapy by exploiting specific genetic vulnerabilities.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) is a primary cause of cancer-related death globally.
- HCC presents significant challenges due to difficulties in targeted treatment and acquired drug resistance.
- Novel therapeutic strategies are essential for improving outcomes in HCC patients.
Purpose of the Study:
- To introduce the concept of synthetic lethality as a therapeutic strategy for HCC.
- To review methods for screening synthetic lethal interactions.
- To discuss identified and potential synthetic lethal interactions relevant to HCC treatment.
Main Methods:
- Review of the concept and screening methodologies for synthetic lethality.
- Analysis of genetic interactions that induce synthetic lethality in HCC.
- Exploration of clinical translation opportunities and challenges.
Main Results:
- Synthetic lethality presents a novel therapeutic avenue for HCC.
- Various screening approaches can identify synthetic lethal partners.
- Several genetic interactions hold potential for targeted HCC therapy.
Conclusions:
- Synthetic lethality offers a promising approach for overcoming drug resistance in HCC.
- Further research and clinical validation are needed to translate these findings into effective treatments.
- Understanding synthetic lethal interactions is crucial for advancing HCC precision medicine.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...